Skip to search formSkip to main contentSkip to account menu

PCI 0123

Known as: PCI-0123 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

motexafin lutetium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Fluorescence pharmacokinetics of Lutetium Texaphyrin (PCI-0123, Lu-Tex) in the skin and in healthy and tumoral hamster cheek-pouch mucosa.
1999
1999
Photodynamic activity of lutetium‐texaphyrin in a mouse tumor system
New photosensitizers proposed for photodynamic therapy (PDT) treatment of tumors need to be evaluated in animal models to… 
Highly Cited
1998
Highly Cited
1998
Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin.
Photodynamic therapy (PDT) of pigmented melanoma has generally been unsuccessful because of insufficient light penetration in… 
1998
1998
Photodynamic therapy trials with lutetium texaphyrin (Lu-Tex) in patients with locally recurrent breast cancer
Photodynamic therapy (PDT) of locally recurrent breast cancer has been limited to treatment of small lesions because of non… 
Highly Cited
1997
Highly Cited
1997
Localization and Efficacy Analysis of the Phototherapeutic Lutetium Texaphyrin (PCI‐0123) in the Murine EMT6 Sarcoma Model
Lutetium texaphyrin (PCI-0123) is a pure, water-soluble photodynamic therapy (PDT) agent that is activated by tissue-penetrating… 
1997
1997
Light-emitting diode versus laser irradiation phototherapy with lutetium texaphyrin (PCI-0123)
Lutetium texaphyrin (PCI-0123) is presently in clinical trials for the treatment of neoplasms. An argon-pumped dye laser has… 
1997
1997
Photoeradication and imaging of atheromatous plaque with texaphyrins
Cardiovascular disease is the chief cause of death in the western world. Lutetium texaphyrin (PCI-0123) is a pure, synthetic… 
Highly Cited
1996
Highly Cited
1996
Phototherapy of cancer and atheromatous plaque with texaphyrins.
Cancer and cardiovascular disease are the leading causes of death in the western world. Photodynamic therapy (PDT) has… 
1996
1996
Influence of drug and light regimens in determining PDT efficacy with lutetium texaphyrin
Lutetium texaphyrin (PCI-0123) is a pure, stabile, water-soluble photosensitizer with a broad absorption band centered at 732 nm… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)